Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Meffin

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Journal of Pharmaceutical Sciences|January 1, 1977
Application of salivary concentration data to pharmacokinetic studies with antipyrineP J Meffin, R L Williams, T F Blaschke, et al.
Clinical Pharmacology and Therapeutics|June 1, 1975
Influence of acute viral hepatitis on phenytoin kinetics and protein bindingT F Blaschke, P J Meffin, K L Melmon, et al.
The Journal of Pharmacy and Pharmacology|December 1, 1978
Effect of phenobarbitone on the disposition of lignocaine and warfarin in the dogM Esquivel, T F Blaschke, G H Snidow, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1979
Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interactionT D Bjornsson, P J Meffin, S Swezey, et al.
Clinical Pharmacology and Therapeutics|November 1, 1978
Dose-dependent acebutolol disposition after oral administrationP J Meffin, R A Winkle, F A Peters, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1986
Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. I. 2-Phenylpropionic acid dispositionP J Meffin, B C Sallustio, Y J Purdie, et al.
Clinical Pharmacology and Therapeutics|November 1, 1977
Acebutolol disposition after intravenous administrationP J Meffin, R A Winkle, F A Peters, et al.
British Journal of Clinical Pharmacology|June 1, 1984
Alterations in prednisolone disposition as a result of oral contraceptive use and doseP J Meffin, L M Wing, B C Sallustio, et al.
Clinical Pharmacology and Therapeutics|February 1, 1980
Saliva and plasma levels and plasma protein binding of clofibrinic acid in uremic patientsT D Bjornsson, P J Meffin, F A Peters, et al.
British Journal of Clinical Pharmacology|October 1, 1977
Acebutolol metabolite plasma concentration during chronic oral therapyR A Winkle, P J Meffin, W B Ricks, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Journal of Pharmaceutical Sciences|January 1, 1977
Application of salivary concentration data to pharmacokinetic studies with antipyrineP J Meffin, R L Williams, T F Blaschke, et al.
Clinical Pharmacology and Therapeutics|June 1, 1975
Influence of acute viral hepatitis on phenytoin kinetics and protein bindingT F Blaschke, P J Meffin, K L Melmon, et al.
The Journal of Pharmacy and Pharmacology|December 1, 1978
Effect of phenobarbitone on the disposition of lignocaine and warfarin in the dogM Esquivel, T F Blaschke, G H Snidow, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1979
Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interactionT D Bjornsson, P J Meffin, S Swezey, et al.
Clinical Pharmacology and Therapeutics|November 1, 1978
Dose-dependent acebutolol disposition after oral administrationP J Meffin, R A Winkle, F A Peters, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1986
Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. I. 2-Phenylpropionic acid dispositionP J Meffin, B C Sallustio, Y J Purdie, et al.
Clinical Pharmacology and Therapeutics|November 1, 1977
Acebutolol disposition after intravenous administrationP J Meffin, R A Winkle, F A Peters, et al.
British Journal of Clinical Pharmacology|June 1, 1984
Alterations in prednisolone disposition as a result of oral contraceptive use and doseP J Meffin, L M Wing, B C Sallustio, et al.
Clinical Pharmacology and Therapeutics|February 1, 1980
Saliva and plasma levels and plasma protein binding of clofibrinic acid in uremic patientsT D Bjornsson, P J Meffin, F A Peters, et al.
British Journal of Clinical Pharmacology|October 1, 1977
Acebutolol metabolite plasma concentration during chronic oral therapyR A Winkle, P J Meffin, W B Ricks, et al.
Pageof 7